reported that an IL2-armed OV promoted the generation and infiltration of tumor-reactive TILs in poorly immunogenic tumors as a pre-TIL approach, and tumor-reactive TILs were harvested and expanded for ACT.48 This evidence concerns the gene IL2 and neoplasm.